COPD

Owlstone will give AstraZeneca access to its Breath Biopsy Services to identify breath-based biomarkers for stratifying and treating asthma and COPD patients.

The partners plan to validate blood-based microRNAs as biomarkers for the early detection of pulmonary and neurodegenerative diseases.

At Bio-IT World, Harvard bioinformatics researcher John Quackenbush called typical methods for determining genetic relevance relics of "Mendel and his peas."

A team of researchers in the UK used a two-stage approach to tie the rare variants to disease risk.

Bio-Techne will provide a bioanalytical assay for the group to assess and validate as a bioanalytical method for clinical trial recruitment.

This Week in PLOS

In PLOS this week: variants that affect COPD biomarkers, high genetic diversity of Cryptococcus gattii in Brazil, and more.

The company is developing a proteomic test for chronic obstructive pulmonary disease that it plans to launch in early 2018 as a CLIA-based diagnostic.

Data for tens of thousands of UK Biobank participants revealed an overlapping set of variants involved in airflow obstruction in heavy and never smokers. 

The technology uses infrared spectroscopy to indentify biomarkers of chronic obstructive pulmonary disease in sputum samples.

NEW YORK (GenomeWeb) – Glyconics, a UK firm using infrared spectroscopy to diagnose respiratory diseases, said today that it recently secured a contract from the Small Business Research Initiative for Healthcare to validate its technology.

Pages

A federal grand jury has indicted Elizabeth Holmes and Ramesh Balwani for alleged wire fraud in conjunction with their activities at Theranos.

Nature News reports that some developers are nervous about GitHub's acquisition by Microsoft.

A direct-to-consumer genetic testing company sent out used spit kits, CNBC reports.

In PLOS this week: comparison of commercial bisulfite kits, new method to predict essential proteins, and more